Tirzepatide and SGLT2 Inhibitors for Heart Failure With Preserved Ejection Fraction and Obesity: Entering a New Cardiometabolic Therapeutic Era. [PDF]
Mohamed ZI +8 more
europepmc +1 more source
Hope for heart failure with preserved ejection fraction? [PDF]
Blanton RM.
europepmc +1 more source
Mitral annular calcification severity and invasive hemodynamic confirmation of HFpEF: A prospective observational study. [PDF]
Cabuk G, Uludag Artun B.
europepmc +1 more source
Heart Failure with Reduced versus Preserved Ejection Fraction: Molecular Mechanisms, Immunologic Pathways, Current Therapies, and Future Directions. [PDF]
Kim E, Agrawal DK.
europepmc +1 more source
Systemic inflammation and the risk of adverse clinical outcomes in heart failure with preserved ejection fraction. [PDF]
Nguyen C +7 more
europepmc +1 more source
Heart Rate Recovery Index as a Functional Marker in Heart Failure with Preserved Ejection Fraction: Associations with H<sub>2</sub>FPEF Score, Longitudinal Systolic Function and Left Atrial Remodelling. [PDF]
Dache A +9 more
europepmc +1 more source
Natriuretic peptide responses to exercise in HFpEF diagnosis: a pilot study. [PDF]
van Ommen AMLN +8 more
europepmc +1 more source
Clonal Hematopoiesis of Indeterminate Potential Proteomic Risk Score for Predicting Clinical Outcome in Patients With Heart Failure With Preserved Ejection Fraction. [PDF]
Kim M +16 more
europepmc +1 more source
Role of Gut Microbiota in Diabetic HFpEF: Mechanisms and Therapeutic Implications. [PDF]
Fan H, Wu J, Shen Y, Zheng W.
europepmc +1 more source

